You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
未名醫藥(002581.SZ)旗下未名天源擬對營口營新化工投資6600萬元
格隆匯 11-29 19:33

格隆匯11月29日丨未名醫藥(002581.SZ)公佈,公司全資子公司山東未名天源生物科技有限公司(“未名天源”)為儘快恢復其盈利能力,擬對營口營新化工科技有限公司(“目標公司”)投資6600萬元,投資後未名天源佔目標公司股份比例為30.56%。

此次對外投資有助於未名天源與美聯新材、營新科技在材料供應、新產品開發等方面建立全面、深度的戰略合作關係,充分發揮和利用三方在各自領域的優勢和資源,提高公司的盈利能力和競爭力。

此次對外投資是公司恢復未名天源盈利能力的重要舉措,也是一次產業戰略投資,未來可能對公司發展和業績提升產生一定的影響,不存在損害上市公司及股東利益的情形。因合資公司尚未全面竣工,短期內不會對公司的經營成果產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account